Mdma molecule:

Image from PubChem

Mdma Clinical Trials

A Multi-Center, Primary Care-Based, Open-Label Study to Assess the Success of Converting Opioid-Experienced Patients, With Chronic, Moderate to Severe Pain, to EMBEDA Using a Standardized Conversion Guide, and to Identify Behaviors Related to Prescription Opioid Abuse, Misuse, and Diversion

To see complete record on, please visit this link

Id: NCT01179191

Organisation Name: Pfizer

Overal Status: Terminated

Start Date: August 2010

Last Update: October 11, 2012

Lead Sponsor: Pfizer

Brief Summary: The purpose of the research study is to find out if opioid dependent chronic pain patients who are judged by their physician to be eligible to change their current opioid medicine and to participate in this study can be successfully adjusted to a stable dose of EMBEDA (morphine sulfate and naltrexone hydrochloride). The study will also assess each patient's risk for prescription opioid abuse, misuse and diversion.

  • Chronic Disease
  • Pain

Total execution time in seconds: 0.51852321624756